21681
paged,wp-singular,page-template,page-template-blog-masonry-full-width,page-template-blog-masonry-full-width-php,page,page-id-21681,paged-42,page-paged-42,wp-theme-stockholm,stockholm-core-2.4,qodef-qi--no-touch,qi-addons-for-elementor-1.11.1,select-theme-ver-9.5,ajax_fade,page_not_loaded,,qode_menu_,wpb-js-composer js-comp-ver-7.9,vc_responsive,elementor-default,elementor-kit-38031,elementor-page elementor-page-21681
Title Image

Blog @ Fordham IPLJ

Fordham Intellectual Property, Media & Entertainment Law Journal

Remdesivir – Worth the Money

In May 2020, the U.S. Food and Drug Administration (“FDA”) issued an emergency use authorization for Gilead’s drug remdesivir to combat COVID-19.[mfn]Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for

Loading new posts...
No more posts